171 related articles for article (PubMed ID: 21520065)
1. Role of the EGFR ligand/receptor system in the secretion of angiogenic factors in mesenchymal stem cells.
De Luca A; Gallo M; Aldinucci D; Ribatti D; Lamura L; D'Alessio A; De Filippi R; Pinto A; Normanno N
J Cell Physiol; 2011 Aug; 226(8):2131-8. PubMed ID: 21520065
[TBL] [Abstract][Full Text] [Related]
2. MEK mediates the novel cross talk between TNFR2 and TGF-EGFR in enhancing vascular endothelial growth factor (VEGF) secretion from human mesenchymal stem cells.
Wang Y; Wang M; Abarbanell AM; Weil BR; Herrmann JL; Tan J; Novotny NM; Coffey AC; Meldrum DR
Surgery; 2009 Aug; 146(2):198-205. PubMed ID: 19628074
[TBL] [Abstract][Full Text] [Related]
3. Preconditioning mesenchymal stem cells with transforming growth factor-alpha improves mesenchymal stem cell-mediated cardioprotection.
Herrmann JL; Wang Y; Abarbanell AM; Weil BR; Tan J; Meldrum DR
Shock; 2010 Jan; 33(1):24-30. PubMed ID: 19996917
[TBL] [Abstract][Full Text] [Related]
4. The role of the EGFR signaling in tumor microenvironment.
De Luca A; Carotenuto A; Rachiglio A; Gallo M; Maiello MR; Aldinucci D; Pinto A; Normanno N
J Cell Physiol; 2008 Mar; 214(3):559-67. PubMed ID: 17894407
[TBL] [Abstract][Full Text] [Related]
5. Gefitinib inhibits the cross-talk between mesenchymal stem cells and prostate cancer cells leading to tumor cell proliferation and inhibition of docetaxel activity.
Borghese C; Cattaruzza L; Pivetta E; Normanno N; De Luca A; Mazzucato M; Celegato M; Colombatti A; Aldinucci D
J Cell Biochem; 2013 May; 114(5):1135-44. PubMed ID: 23192362
[TBL] [Abstract][Full Text] [Related]
6. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
Gacche RN; Meshram RJ
Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
[TBL] [Abstract][Full Text] [Related]
7. IL-6 and TGF-α costimulate mesenchymal stem cell vascular endothelial growth factor production by ERK-, JNK-, and PI3K-mediated mechanisms.
Herrmann JL; Weil BR; Abarbanell AM; Wang Y; Poynter JA; Manukyan MC; Meldrum DR
Shock; 2011 May; 35(5):512-6. PubMed ID: 21263382
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta1 enhanced vascular endothelial growth factor synthesis in mesenchymal stem cells.
Wang XJ; Dong Z; Zhong XH; Shi RZ; Huang SH; Lou Y; Li QP
Biochem Biophys Res Commun; 2008 Jan; 365(3):548-54. PubMed ID: 18023419
[TBL] [Abstract][Full Text] [Related]
9. SRC family kinases mediate epidermal growth factor receptor ligand cleavage, proliferation, and invasion of head and neck cancer cells.
Zhang Q; Thomas SM; Xi S; Smithgall TE; Siegfried JM; Kamens J; Gooding WE; Grandis JR
Cancer Res; 2004 Sep; 64(17):6166-73. PubMed ID: 15342401
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression.
Rusch V; Klimstra D; Venkatraman E; Pisters PW; Langenfeld J; Dmitrovsky E
Clin Cancer Res; 1997 Apr; 3(4):515-22. PubMed ID: 9815714
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cells from primary breast cancer tissue promote cancer proliferation and enhance mammosphere formation partially via EGF/EGFR/Akt pathway.
Yan XL; Fu CJ; Chen L; Qin JH; Zeng Q; Yuan HF; Nan X; Chen HX; Zhou JN; Lin YL; Zhang XM; Yu CZ; Yue W; Pei XT
Breast Cancer Res Treat; 2012 Feb; 132(1):153-64. PubMed ID: 21584665
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of TNF-α-induced migration and hepatocyte growth factor production in human mesenchymal stem cells.
Zhang A; Wang Y; Ye Z; Xie H; Zhou L; Zheng S
J Cell Biochem; 2010 Oct; 111(2):469-75. PubMed ID: 20533298
[TBL] [Abstract][Full Text] [Related]
13. Expression of growth factors, growth-inhibiting factors, and their receptors in invasive breast cancer. II: Correlations with proliferation and angiogenesis.
de Jong JS; van Diest PJ; van der Valk P; Baak JP
J Pathol; 1998 Jan; 184(1):53-7. PubMed ID: 9582527
[TBL] [Abstract][Full Text] [Related]
14. Complex post-transcriptional regulation of EGF-receptor expression by EGF and TGF-alpha in human prostate cancer cells.
Seth D; Shaw K; Jazayeri J; Leedman PJ
Br J Cancer; 1999 May; 80(5-6):657-69. PubMed ID: 10360641
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal stem cell-derived interleukin-6 and vascular endothelial growth factor promote breast cancer cell migration.
De Luca A; Lamura L; Gallo M; Maffia V; Normanno N
J Cell Biochem; 2012 Nov; 113(11):3363-70. PubMed ID: 22644871
[TBL] [Abstract][Full Text] [Related]
16. Differential effect of FGF and PDGF on cell proliferation and migration in osteoblastic cells.
Kim SJ; Kim SY; Kwon CH; Kim YK
Growth Factors; 2007 Apr; 25(2):77-86. PubMed ID: 17852407
[TBL] [Abstract][Full Text] [Related]
17. Angiogenic activity of mesenchymal stem cells in multiple myeloma.
Wang X; Zhang Z; Yao C
Cancer Invest; 2011 Jan; 29(1):37-41. PubMed ID: 21166497
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung.
Rusch V; Baselga J; Cordon-Cardo C; Orazem J; Zaman M; Hoda S; McIntosh J; Kurie J; Dmitrovsky E
Cancer Res; 1993 May; 53(10 Suppl):2379-85. PubMed ID: 7683573
[TBL] [Abstract][Full Text] [Related]
19. Osteopontin-induced migration of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathways.
Tuck AB; Hota C; Wilson SM; Chambers AF
Oncogene; 2003 Feb; 22(8):1198-205. PubMed ID: 12606946
[TBL] [Abstract][Full Text] [Related]
20. Role of TGF alpha stimulation of the ERK, PI3 kinase and PLC gamma pathways in ovarian cancer growth and migration.
Sewell JM; Smyth JF; Langdon SP
Exp Cell Res; 2005 Mar; 304(1):305-16. PubMed ID: 15707595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
